Introduction
============

Lung function variables including residual volume (RV)/total lung capacity (TLC), inspiratory capacity (IC)/TLC, RV% predicted and forced expiratory volume in one second percentage predicted (FEV~1~%) have been reported to be well correlated with the outcomes of patients with chronic obstructive pulmonary disease (COPD) including physiological deterioration, dyspnea, exercise intolerance, acute exacerbations, and mortality ([@ref-30]; [@ref-29]; [@ref-7]; [@ref-36]; [@ref-37]; [@ref-40]; [@ref-8]; [@ref-35]). Correlations between lung function variables and outcomes have been reported sporadically, such as associations between IC/TLC and RV/TLC and prognosis, ([@ref-29]; [@ref-7]; [@ref-35]) exercise capacity, ([@ref-37]; [@ref-40]; [@ref-8]) exertional dyspnea, ([@ref-7]; [@ref-40]; [@ref-8]) and dynamic lung expansion ([@ref-40]; [@ref-8]) in patients with COPD. Moreover, IC/TLC and RV/TLC have been reported to have very similar Harrell's C-statistics in prognostic analysis ([@ref-35]). However, as the independent contributions of IC/TLC and RV/TLC to outcomes would be lower when they are modelled together if they are highly correlated, it is important to investigate the relationships among lung function variables.

Hyperinflation and air trapping are defined using lung volumes in percentages (%) combined with ratios of functional residual capacity (FRC), IC or RV and TLC ([@ref-32]; [@ref-14]; [@ref-10]; [@ref-38]). However, these definitions are unclear and arbitrary and understanding the relationships among these variables may improve the definitions.

It has also been reported that TLC measurements are not necessary after spirometry data have been obtained. However, this will not be the case if forced vital capacity (FVC) cannot predict TLC, as obstructive ventilatory impairment may be combined with restriction in patients with COPD ([@ref-13]; [@ref-29]; [@ref-6]; [@ref-12]; [@ref-21]; [@ref-35]). To resolve these three issues, this study aimed to thoroughly evaluate the relationships among lung function parameters using factor and correlation analyses.

Methods
=======

Study design
------------

In this observational cross-sectional study, we analyzed lung function data from participants with COPD at Chung Shan Medical University Hospital. A total of 26 lung volume and capacity parameters were expressed in liters, %predicted, and ratio of TLC, FVC and SVC ([Appendix 1](#app-group-1){ref-type="app"}). The Chung Shan Medical University Hospital Institutional Review Board (CS11144 and CS19014) approved this study, which was conducted in compliance with the Declaration of Helsinki.

Participants
------------

The diagnosis of COPD was made by board-certified pulmonologists according to the GOLD criteria ([@ref-17]). Participants with other thoracic diseases such as pleural diseases or thoracic cage disorders were excluded from this study ([@ref-17]). As few female participants meet the COPD criteria in Taiwan (e.g., 4% according to one study [@ref-19]), they were excluded from this study. Male adult participants with a post-bronchodilator FEV~1~/FVC of \<0.7 ([@ref-17]) or 0.7--0.8 with a definite obstructive pattern in spirometry were enrolled ([@ref-20]). The latter definition was used for two reasons. First, extensive small airway disease can exist before it is detectable with a FEV~1~/FVC \<0.7, and thus the concavity of expiratory flow-volume curve was considered ([@ref-20]). Second, some participants with increased small airway compressibility had a preserved FEV~1~/FVC but a reduced FEV~1~/slow VC ratio ([@ref-20]; [@ref-34] (in press)). The exclusion criteria included a FEV~1~/FVC of 0.7--0.8 with an equivocal obstructive pattern or with a significant post-bronchodilator effect, i.e., increase in FEV~1~ of \>12% and 200 mL from baseline ([@ref-16]) or bronchial asthma ([@ref-16]) diagnosed by the board-certified pulmonologists. Bronchial asthma was excluded because the proportion of lung subdivisions is different in these two diseases ([@ref-13]). Informed consent was obtained from each participant by them signing the consent form.

Measurements
------------

### Pulmonary function testing

Cigarette smoking, drinking coffee, tea, or alcohol, and taking medications were not permitted 24 h before any test. Bronchodilators were not administered within 3 h for short-acting beta agonists and 12 h for long-acting beta agonists before the tests. FEV~1~, TLC, and RV were measured using spirometry and body plethysmography (MasterScreen™ Body; Carefusion, Wuerzburg, Germany) in accordance with the currently recommended standards ([@ref-27]; [@ref-28]; [@ref-39]). The best of three technically satisfactory readings was used ([@ref-4]; [@ref-27]; [@ref-28]). All of the spirometry data were obtained before and after inhaling 400 µg of fenoterol HCl. Post-dose measurements were performed 15 min after inhalation. Static lung volume data and diffusing capacity for carbon monoxide (D~L~CO) data measured using the single-breath technique were obtained before inhaling fenoterol. For details of lung subdivision measurements, please refer to [Appendix 2](#app-group-1){ref-type="app"}. Simple volume calibration was conducted using a 3-L syringe before each test. Accuracy checks for body plethysmograph mouth flow and pressure and box pressure were conducted daily. We have previously reported the predicted values currently used at our institute. The predicted values are in line with our previous report ([@ref-9]). The reason that we did not use lower limit of normal as the criterion of airflow limitation was that we did not have reference equations using post-bronchodilator FEV~1~ and FVC for the Taiwanese population.

Statistical analysis
--------------------

All of the data were checked for normal distribution by the Kolmogorov--Smirnov test. Data were summarized as mean ± standard deviation or median (25th--75th percentiles) when appropriate. We used factor analysis to evaluate the correlated pulmonary function variables and identify the latent factors. We extracted the initial set of factors using the principal-component method based on the Kaiser criterion, then 1-more and 1-fewer factor models were also evaluated. The factors were then rotated using an orthogonal transformation method (VARIMAX in SAS) to assess the interpretability of the factors. The numbers of factors determined in the final model was based on biological plausibility. Pearson's or Spearman's correlation coefficients were further used when appropriate for quantifying the pair-wise relationships among the pulmonary function variables. All statistical analyses were performed using SAS statistical software (SAS Institute Inc., Cary, NC, USA). Statistical significance was set at two-sided *p* \<0.05.

Results
=======

A total of 94 male participants (mean age 68.1 ± 7.2 years) with COPD were enrolled after excluding 10 participants ([Table 1](#table-1){ref-type="table"} and [Fig. 1](#fig-1){ref-type="fig"}). Five of these 10 participants who were excluded were diagnosed with bronchial asthma including three females and another five had spirometry data that did not meet the inclusion criteria. Only five of the 94 participants had a FEV~1~/FVC ratio 0.7--0.8 with a definite obstructive pattern. Most of the participants had moderate airflow obstruction ([Table 1](#table-1){ref-type="table"}).
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###### Demographics and lung function in 94 participants with chronic obstructive pulmonary disease.
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                                                                                     Mean      SD
  ---------------------------------------------------------------------------------- --------- ------------------------------------------
  Age, years                                                                         68.1      7.2
  Height, cm                                                                         164.5     5.8
  Weight, kg                                                                         61.3      9.6
  Body mass index, kg/m^2^                                                           22.6      3.2
  Cigarette smoke[^a^](#table-1fn2){ref-type="fn"}, pack . year                      45        35.5--60[^e^](#table-1fn){ref-type="fn"}
  TLC% predicted[^a^](#table-1fn2){ref-type="fn"}, %                                 116       103--137[^e^](#table-1fn){ref-type="fn"}
  FRC% predicted[^a^](#table-1fn2){ref-type="fn"}, %                                 143       35
  FRC/TLC[^a^](#table-1fn2){ref-type="fn"}                                           0.71      0.08
  RV% predicted[^a^](#table-1fn2){ref-type="fn"}, %                                  170       55
  RV/TLC[^a^](#table-1fn2){ref-type="fn"}                                            0.56      0.09
  Expiratory reserve volume, ERV% predicted[^a^](#table-1fn2){ref-type="fn"}, %      82        55--121[^e^](#table-1fn){ref-type="fn"}
  ERV/TLC[^a^](#table-1fn2){ref-type="fn"}                                           0.15      0.08
  IC% predicted[^a^](#table-1fn2){ref-type="fn"}, %                                  87        26
  IC/TLC[^a^](#table-1fn2){ref-type="fn"}                                            0.29      0.08
  Inspiratory reserve volume, IRV% predicted[^a^](#table-1fn2){ref-type="fn"}, %     78        47
  IRV/TLC[^a^](#table-1fn2){ref-type="fn"}                                           0.15      0.09
  D~L~CO% predicted, %, unadjusted for Hemoglobin[^b^](#table-1fn3){ref-type="fn"}   76        26
  FVC% predicted, %                                                                  83        22
  FEV~1~% predicted, %                                                               54        19
  Mild, FEV~1~% ≥80%[^d^](#table-1fn3){ref-type="fn"}, n, %                          8 (9)     
  Moderate, 50% ≤ FEV~1~%\<80%[^d^](#table-1fn5){ref-type="fn"}, n, %                47 (50)   
  Severe, 30% ≤ FEV~1~%\<50%[^d^](#table-1fn5){ref-type="fn"}, n, %                  30 (32)   
  Very severe, FEV~1~%\<30%[^d^](#table-1fn5){ref-type="fn"}, n, %                   9 (10)    
  FEV~1~/FVC                                                                         0.51      0.12
  SVC% predicted[^c^](#table-1fn4){ref-type="fn"}, %                                 82        70--107[^e^](#table-1fn4){ref-type="fn"}

**Notes.**

TLCtotal lung capacityLliterFRCfunctional residual capacityRVresidual volumeICinspiratory capacityD~L~COdiffusing capacity for carbon monoxideFVCforced vital capacityFEV~1~forced expired volume in one secondSVCslow vital capacity

*n* = 92.

*n* = 88.

*n* = 91.

[@ref-17].

median (25th--75th percentiles).

Up to 26 lung function parameters were presented in absolute values, %predicted, and as the ratio of lung volume or capacity and TLC or FVC for each patient. In normal participants, lung volume in liters was closely related to body height, sex, and age and hence it was usually presented with %predicted. Therefore, the following variables were omitted from correlation analysis: TLC, FRC, IC, IRV, ERV, RV, FVC, SVC, and FEV~1~ in liters and D~L~CO in mL/min/mmHg.

Factor analysis
---------------

A preliminary model with four factors were selected by the Kaiser criterion and then the 3-factor and 5-factor models were also evaluated. The five latent factor model was identified according to biological plausibility and this model explained 92% of total variation ([Table 2](#table-2){ref-type="table"}). The communalities were generally high (12 of 16 were \>0.9, three were between 0.75 and 0.9, and only one was 0.4). Factor 1 was highly related to inspiration and moderately to air trapping; factor 2 was highly related to lung volumes and moderately to air trapping; factor 3 was highly related to expiration and moderately to air trapping; factor 4 was highly related to airflow obstruction; and factor 5 was highly related to diffusion capacity.

![Flow diagram.\
A total of 104 participants with chronic obstructive pulmonary disease were screened. 94 patients were enrolled and analyzed after excluding 10 participants. Of the 94 participants, two participants missed the lung volume measurements, and six participants missed diffusing capacity for carbon monoxide. The differences in demographic data and spirometry between the six and 88 participants were not statistically significant except body weight and body mass index (54.5 ± 3.0 kg versus 61.7 ± 9.7 kg, *p* \< 0.001 and 20.9 ± 1.3 kg/m^2^ versus 22.7 ± 3.2 kg/m^2^, *p* \< 0.05, respectively).](peerj-07-7829-g001){#fig-1}
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###### Factor analysis showing rotated component matrix[^a^](#table-2fn2){ref-type="fn"}.
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               Factors                                     
  ------------ ---------- ---------- ---------- ---------- ----------
  TLC%p        0.27       **0.93**   0.17       −0.10      −0.10
  FRC%p        −0.20      **0.94**   0.11       −0.13      −0.08
  FRC/TLC      *−0.68*    0.65       0.10       −0.21      −0.07
  RV%p         −0.07      **0.89**   −0.32      −0.13      −0.16
  RV/TLC       −0.39      *0.53*     *−0.67*    −0.16      −0.14
  IC%p         **0.96**   .011       0.08       0.09       −0.03
  IC/TLC       *0.67*     *−0.66*    −0.10      0.21       0.04
  IRV%p        **0.94**   0.07       0.10       0.01       −0.03
  IRV/TLC      **0.86**   −0.19      0.03       −0.01      0.13
  ERV%p        −0.18      0.22       **0.91**   −0.04      0.14
  ERV/TLC      −0.24      0.02       **0.91**   −0.03      0.09
  D~L~CO%p     0.07       −0.25      0.19       0.18       **0.92**
  FVC%p        0.48       −0.09      *0.76*     0.12       −0.04
  FEV~1~%p     0.37       −0.26      *0.54*     *0.65*     0.06
  FEV~1~/FVC   −0.00      −0.22      −0.04      **0.94**   0.15
  SVC%p        *0.57*     0.06       *0.77*     0.08       0.04

**Notes.**

For all abbreviations, please refer to [Table 1](#table-1){ref-type="table"}. Extraction method: Principal component analysis. Rotation method: Varimax with Kaiser normalization.

Rotation converged in 5 iterations.

Bolded number indicating the important variables (arbitrarily defined as value \>0.85) in that factor, Italic number indicating the variables with moderate importance (arbitrarily defined as value \> 0.50) in that factor.

Pearson's or Spearman's correlation coefficients for lung volume subdivisions
-----------------------------------------------------------------------------

All *r*^2^, the coefficient of determination for Pearson's correlations, indicated the proportion of variance in one variable explained by variation in the other. Individual variables involving %predicted were strongly correlated with each corresponding variable in ratio of TLC ([Table 3](#table-3){ref-type="table"}, all *r*^2^ = 0.38 − 0.85, all *p* \< 0.0001). TLC%, FRC%, and RV% were highly correlated (*r*^2^ = 0.59 − 0.74). RV% was the best single parameter correlated with D ~L~CO%, although only with a negative moderate correlation (*r*^2^ = 0.22, *p* \< 0.0001). FRC/TLC and IC/TLC were reciprocal (*r*^2^ = 0.98) and highly correlated with RV/TLC (*r*^2^ = 0.37-0.38), and were most frequently correlated with all of the other lung subdivisions in %predicted and ratio of TLC. IC% and IRV% were approximately collinear (*r*^2^ = 0.90).
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###### Pearson Correlations (r) Pair-Wise Deletion between lung volumes in 92[^a^](#table-3fn7){ref-type="fn"} participants with obstructive airway disease.
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                                           TLC%[^\#^](#table-3fn2){ref-type="fn"}   FRC%                                    FRC/TLC                                 RV%                                     RV/TLC                                     ERV%[^\#^](#table-3fn2){ref-type="fn"}      ERV/TLC                                    IC%                                        IC/TLC                                      IRV%                                     IRV/TLC                                     D~L~CO%
  ---------------------------------------- ---------------------------------------- --------------------------------------- --------------------------------------- --------------------------------------- ------------------------------------------ ------------------------------------------- ------------------------------------------ ------------------------------------------ ------------------------------------------- ---------------------------------------- ------------------------------------------- -------------------------------------------
  TLC%[^\#^](#table-3fn2){ref-type="fn"}                                            0.86[^§^](#table-3fn3){ref-type="fn"}   0.44[^§^](#table-3fn3){ref-type="fn"}   0.77[^§^](#table-3fn3){ref-type="fn"}   0.26[^\*\*^](#table-3fn5){ref-type="fn"}   −0.27[^\*\*^](#table-3fn5){ref-type="fn"}   NS                                         0.33[^\*\*^](#table-3fn5){ref-type="fn"}   −0.46[^§^](#table-3fn3){ref-type="fn"}      0.41[^§^](#table-3fn3){ref-type="fn"}    NS                                          −0.28[^\*\*^](#table-3fn5){ref-type="fn"}
  FRC%                                                                                                                      0.75[^§^](#table-3fn3){ref-type="fn"}   0.87[^§^](#table-3fn3){ref-type="fn"}   0.52[^§^](#table-3fn3){ref-type="fn"}      0.32[^\*\*^](#table-3fn5){ref-type="fn"}    NS                                         NS                                         −0.76[^§^](#table-3fn3){ref-type="fn"}      NS                                       −0.28[^\*\*^](#table-3fn5){ref-type="fn"}   −0.34[^\*\*^](#table-3fn5){ref-type="fn"}
  FRC/TLC                                                                                                                                                           0.62[^§^](#table-3fn3){ref-type="fn"}   0.62[^§^](#table-3fn3){ref-type="fn"}      0.29[^\*\*^](#table-3fn5){ref-type="fn"}    0.29[^\*\*^](#table-3fn5){ref-type="fn"}   −0.63[^§^](#table-3fn3){ref-type="fn"}     −0.99[^§^](#table-3fn3){ref-type="fn"}      −0.53[^§^](#table-3fn3){ref-type="fn"}   −0.65[^§^](#table-3fn3){ref-type="fn"}      −0.29[^\*\*^](#table-3fn5){ref-type="fn"}
  RV%                                                                                                                                                                                                       0.71[^§^](#table-3fn3){ref-type="fn"}      NS                                          −0.23[^\*^](#table-3fn6){ref-type="fn"}    NS                                         −0.63[^§^](#table-3fn3){ref-type="fn"}      NS                                       −0.22[^\*^](#table-3fn6){ref-type="fn"}     −0.47[^§^](#table-3fn3){ref-type="fn"}
  RV/TLC                                                                                                                                                                                                                                               −0.45[^§^](#table-3fn3){ref-type="fn"}      −0.57[^§^](#table-3fn3){ref-type="fn"}     −0.44[^§^](#table-3fn3){ref-type="fn"}     −0.61[^§^](#table-3fn3){ref-type="fn"}      −0.38⑤                                   −0.51[^§^](#table-3fn3){ref-type="fn"}      −0.43[^§^](#table-3fn3){ref-type="fn"}
  ERV%[^\#^](#table-3fn2){ref-type="fn"}                                                                                                                                                                                                                                                           0.92[^§^](#table-3fn3){ref-type="fn"}      NS                                         −0.30[^\*\*^](#table-3fn5){ref-type="fn"}   NS                                       NS                                          NS
  ERV/TLC                                                                                                                                                                                                                                                                                                                                     NS                                         −0.27[^\*\*^](#table-3fn5){ref-type="fn"}   NS                                       NS                                          0.21[^\*^](#table-3fn6){ref-type="fn"}
  IC%                                                                                                                                                                                                                                                                                                                                                                                    0.62[^§^](#table-3fn3){ref-type="fn"}       0.95[^§^](#table-3fn3){ref-type="fn"}    0.77[^§^](#table-3fn3){ref-type="fn"}       NS
  IC/TLC                                                                                                                                                                                                                                                                                                                                                                                                                             0.52[^§^](#table-3fn3){ref-type="fn"}    0.65[^§^](#table-3fn3){ref-type="fn"}       0.27[^\*^](#table-3fn6){ref-type="fn"}
  IRV%                                                                                                                                                                                                                                                                                                                                                                                                                                                                        0.77[^§^](#table-3fn3){ref-type="fn"}       NS
  IRV/TLC                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 0.21[^\*^](#table-3fn6){ref-type="fn"}

**Notes.**

TLCtotal lung capacityFRCfunctional residual capacityRVresidual volumeERVexpiratory reserve volumeICinspiratory capacityIRVinspiratory reserve volumeD~L~COdiffusing capacity for carbon monoxide%% predicted

Spearman correlation coefficient.

*p* \< 0.0001.

*p* \< 0.001.

*p* \< 0.01.

*p* \< 0.05.

Two of 94 participants missed lung volume measurements.

NSnon-significant

Pearson's or Spearman's correlation coefficients for spirometry variables
-------------------------------------------------------------------------

FVC% and SVC% were highly correlated with FEV~1~% (*r*^2^ = 0.38 − 0.74, [Table 4](#table-4){ref-type="table"}); however, they were not correlated with FEV~1~/FVC (*r*^2^ = 0.00-0.00). Interestingly, FEV~1~% and FEV~1~/FVC were related (*r*^2^ = 0.40).
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###### Pearson Correlations (r) Pair-Wise Deletion between lung volumes and spirometry in participants with obstructive airway disease.
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                                           FVC%                                        FEV~1~%                                    FEV~1~/FVC                                  SVC%%[^\#^](#table-4fn2){ref-type="fn"}
  ---------------------------------------- ------------------------------------------- ------------------------------------------ ------------------------------------------- -------------------------------------------
  FVC%                                                                                 0.77[^§^](#table-4fn3){ref-type="fn"}      0.04                                        0.86[^§^](#table-4fn3){ref-type="fn"}
  FEV~1~%                                                                                                                         0.63[^§^](#table-4fn3){ref-type="fn"}       0.62[^§^](#table-4fn3){ref-type="fn"}
  FEV~1~/FVC                                                                                                                                                                  −0.03
  TLC%[^\#^](#table-4fn2){ref-type="fn"}   0.20[^\*^](#table-4fn6){ref-type="fn"}      −0.11                                      −0.32[^\*\*^](#table-4fn5){ref-type="fn"}   0.39[^†^](#table-4fn4){ref-type="fn"}
  FRC%                                     −0.09                                       −0.35[^†^](#table-4fn4){ref-type="fn"}     −0.36[^†^](#table-4fn4){ref-type="fn"}      0.09
  FRC/TLC                                  −0.33[^\*\*^](#table-4fn5){ref-type="fn"}   −0.50[^§^](#table-4fn3){ref-type="fn"}     −0.36[^†^](#table-4fn4){ref-type="fn"}      −0.28[^\*\*^](#table-4fn5){ref-type="fn"}
  RV%                                      −0.29[^\*\*^](#table-4fn5){ref-type="fn"}   −0.48[^§^](#table-4fn3){ref-type="fn"}     −0.35[^†^](#table-4fn4){ref-type="fn"}      −0.20
  RV/TLC                                   −0.65[^§^](#table-4fn3){ref-type="fn"}      −0.67[^§^](#table-4fn3){ref-type="fn"}     −0.28[^\*\*^](#table-4fn5){ref-type="fn"}   −0.67[^§^](#table-4fn3){ref-type="fn"}
  ERV%[^\#^](#table-4fn2){ref-type="fn"}   0.43[^§^](#table-4fn3){ref-type="fn"}       0.27[^\*\*^](#table-4fn5){ref-type="fn"}   −0.07                                       0.58[^§^](#table-4fn3){ref-type="fn"}
  ERV/TLC                                  0.45[^§^](#table-4fn3){ref-type="fn"}       0.29[^\*\*^](#table-4fn5){ref-type="fn"}   −0.03                                       0.50[^§^](#table-4fn3){ref-type="fn"}
  IC%                                      0.51[^§^](#table-4fn3){ref-type="fn"}       0.44[^§^](#table-4fn3){ref-type="fn"}      0.08                                        0.62[^§^](#table-4fn3){ref-type="fn"}
  IC/TLC                                   0.32[^\*\*^](#table-4fn5){ref-type="fn"}    0.49[^§^](#table-4fn3){ref-type="fn"}      0.36[^†^](#table-4fn4){ref-type="fn"}       0.25[^\*^](#table-4fn6){ref-type="fn"}
  IRV%                                     0.50[^§^](#table-4fn3){ref-type="fn"}       0.37[^†^](#table-4fn4){ref-type="fn"}      0.01                                        0.63[^§^](#table-4fn3){ref-type="fn"}
  IRV/TLC                                  0.32[^\*\*^](#table-4fn5){ref-type="fn"}    0.29[^\*\*^](#table-4fn5){ref-type="fn"}   0.06                                        0.51[^§^](#table-4fn3){ref-type="fn"}
  D~L~CO%                                  0.19                                        0.34[^\*\*^](#table-4fn5){ref-type="fn"}   0.29[^\*\*^](#table-4fn5){ref-type="fn"}    0.18

**Notes.**

TLCtotal lung capacityFRCfunctional residual capacityRVresidual volumeERVexpiratory reserve volumeICinspiratory capacityIRVinspiratory reserve volumeD~L~COdiffusing capacity for carbon monoxideFVCforced vital capacityFEV~1~forced expired volume in one secondSVCslow vital capacity%% predicted

Spearman correlation coefficient.

*p* \< 0.0001.

*p* \< 0.001.

*p* \< 0.01.

*p* \< 0.05.

*n* = 94 having spirometry, 92 having lung volume measurements, and 88 having D~L~CO.

Pearson's or Spearman's correlation coefficients between spirometry and lung volume subdivisions
------------------------------------------------------------------------------------------------

FVC% and FEV~1~% were modestly or not correlated with TLC% ([Table 4](#table-4){ref-type="table"}, *r*^2^ = 0.01--0.04) despite being correlated with most of the subdivisions in %predicted and ratio of TLC. Of 89 participants with FEV~1~/FVC \<0.7, 81 (91%) had IC/TLC \<0.4 and 85 (96%) had RV/TLC ≥0.4.

Based on these results, TLC%, RV/TLC (or FEV~1~/FVC), FEV~1~%, and D ~L~ CO% were selected from the five factors as representative of lung function.

Discussion
==========

Factor analysis and Pearson's or Spearman's correlation coefficients
--------------------------------------------------------------------

Factor analysis is a good method to identify unobservable factors from a large number of observed variables, thereby allowing variables to be used to estimate a lower number of latent factors. In this study, we identified five latent factors, i.e., those highly related to inspiration, expiration, lung volumes, airflow obstruction, and diffusion, respectively ([Table 2](#table-2){ref-type="table"}). However, lung volumes and inspiration and expiration volumes were also mixed with air trapping, suggesting that hyperinflation and air trapping overlapped (see below). In further analysis, Pearson's or Spearman's correlation coefficients revealed the lung function variables associated with hyperinflation and air trapping ([Table 3](#table-3){ref-type="table"}).

However, it is possible that the small sample size would not meet the usual heuristics for principle component analysis or factor analysis, and that this would mean it was difficult to explain the implications of the non-normality and outliers in the data. Although the sample size of the present study was small at 88, the influence of the small sample size depends on the data characteristics. Previous studies have shown that even a small sample size of fewer than 50 participants can yield results with small distortions under data conditions of high loading, low number of factors, and high number of variables ([@ref-11]). When communalities are high, the sample size tends to have less influence on the quality of factor solutions than when communalities are low [@ref-18]. We only had limited data; however, the communalities were generally high (12 of 16 were \>0.90, three were between 0.75 and 0.90, and only one was 0.40) in our final factor model. Spearman's correlation coefficients were applied for the pairs involving non-normality ([Tables 3](#table-3){ref-type="table"} and [4](#table-4){ref-type="table"}) and the results were not substantially different from those using the Pearson's correlations. Therefore, we assumed that the potential non-normality might not substantially influence the current results of factor analysis.

In addition, one may argue the rationale for using the Kaiser criterion for selecting a preliminary model in this study. While both the Kaiser criterion and parallel analysis use information from eigenvalues of the correlation matrix, the latter can be used to determine more consistently the number of factors, especially in small samples. As appropriate factor retention would depend on biological plausibility rather than purely on statistical consideration, we used the Kaiser criterion to determine the preliminary model, and then selected a five-factor final model (as stated in the previous sections). One of the purposes of this study was to explore different domains (latent factors) related to individual lung function parameters. Rotation makes latent factors more interpretable. We used VARIMAX, an orthogonal rotation that did not change the communalities and the total variance explained (still 92%) while preserving correlations between variables ([@ref-31]).

Lung volume subdivisions
------------------------

It has been frequently reported that both IC/TLC and RV/TLC are related to prognosis, exercise capacity, exertional dyspnea, and dynamic lung expansion in patients with COPD. Similarly, IC/TLC and RV/TLC have been reported to have very similar Harrell's C-statistics in prognostic analysis (0.81 and 0.80, respectively, [Table 4](#table-4){ref-type="table"} of reference ([@ref-35]). We hypothesize that IC/TLC and RV/TLC have similar Harrell's C-statistics because of their collinearity.

RV% was the largest and the most frequent responder following bronchodilation in a previous report ([@ref-12]). In the present study, it showed the best inverse but moderate correlation of all lung function variables with D ~L~CO%.

Definitions of pulmonary hyperinflation and air trapping of the lung are inconsistent in the literature, for example: static hyperinflation = hyperinflation at rest ([@ref-14]) = IC/TLC \<0.25 ([@ref-7]) = RV/TLC ([@ref-29]; [@ref-5]) ≥0.4 ([@ref-3]; [@ref-35]) or \>0.35 plus an increased TLC ([@ref-32]) or \>0.3 plus RV% ≥120% ([@ref-21]); air trapping = RV/TLC \>0.35 plus a normal TLC ([@ref-32]) or RV% ≥120% ([@ref-12]). To some extent, these definitions overlap RV, IC and TLC and their derivatives. In addition, the relationship between RV/TLC and TLC% is inconsistent in previous reports ([@ref-12]; [@ref-38]). Despite knowing that factor three involved lung volumes, we further evaluated the relationships among all lung subdivisions with Pearson's or Spearman's correlation, and found that RV%, FRC%, and TLC% were highly correlated (*r*^2^ = 0.59--0.74), and that RV/TLC, FRC/TLC and IC/TLC were also highly correlated (*r*^2^ = 0.37--0.98). In contrast, the correlations of RV/TLC, FRC/TLC and IC/TLC with TLC% were only *r*^2^ = 0.08, 0.18, and 0.20, respectively.

RV, FRC, and TLC in %predicted are all related to static lung volume ([@ref-14]; [@ref-38]). RV% is mainly composed of FRC%, ([@ref-13]) and FRC% is mainly composed of TLC% in COPD. This is consistent with a previous report in which RV% was highly correlated with FRC% (*r* = 0.9) ([@ref-12]). Therefore, we recommend that RV%, FRC%, and TLC% can be used as biomarkers for hyperinflation, and that RV/TLC and IC/TLC (reciprocal FRC/TLC) can be used as biomarkers for air trapping, even though these two types of biomarkers are closely related. It makes sense that the IC/TLC triad is more sensitive than RV% ([@ref-3]; [@ref-40]) and FEV~1~% in relation to exercise capacity, as the IC/TLC triad, RV% and FEV~1~% belong to different factors, denoting that air trapping plays a more important role in exercise capacity than hyperinflation and airflow obstruction ([@ref-40]).

Spirometry and lung volume subdivisions
---------------------------------------

The need for simultaneous measurements of lung volume and spirometry is controversial. FEV~1~/FVC, a biomarker of airway obstruction, was significantly correlated with the biomarkers for air trapping and hyperinflation in this study ([Table 4](#table-4){ref-type="table"}). Airway obstruction can easily be assessed using spirometry. Therefore, additional measurements of static lung volume add little to the clinical interpretation. This is consistent with the study by Dykstra et al., in which 87% of 1,872 patients with reduced vital capacity had a high RV/TLC, and only 10% had a low TLC% ([@ref-13]). This concept was further confirmed in their report as FEV~1~% was reported to predict RV%, RV/TLC, and TLC% (*r* =  − 0.76, −0.66 and −0.33, respectively, all *p* \< 0.0001) ([@ref-13]). Another study reported that a low FVC% with a low FEV~1~/FVC ratio could be used as a marker of obstructive ventilation with "pseudo-restriction" ([@ref-1]). However, 10% of the patients in Dykstra's study had a low TLC%, suggesting the coexistence of a mixed type (obstructive-restrictive impairment) ([@ref-13]). In addition, another study reported that 8% of asthmatics had restricted ventilation ([@ref-26]). Gardner et al. reported that restriction of the lung may interfere with classifying the severity of obstruction in patients with mixed obstructive-restrictive lung disease according to FEV~1~% adjusted for TLC%. This adjustment resulted in the downgrading of 83% of their patients to a lesser degree of obstruction ([@ref-15]; [@ref-1]) reported that a reduced FVC could only predict a reduced TLC by 40--50%. Moreover, regarding the effect of bronchodilators on COPD, measurements of lung volume response may be superior to those of flow response ([@ref-12]; [@ref-25]). Hence, we disagree with the notion that lung volume measurements are not necessary for patients with reduced VC, ([@ref-13]) as FVC% and FEV~1~% were modestly or not correlated with TLC% in the present (*r*^2^ = 0.04 and 0.01, [Table 4](#table-4){ref-type="table"}), and previous studies ([@ref-13]; [@ref-25]) and were not correlated with expandable lung volumes ([Table 4](#table-4){ref-type="table"}, IC%, IRV%, ERV%, and IRV/TLC and ERV/TLC). The smaller the FEV~1~%, the larger the RV% and RV/TLC, even though TLC% had probably yet to change ([@ref-38]).

FEV~1~% was also linearly related to IC ([@ref-12]) and VC% ([@ref-29]; [@ref-12]) in this study, as FEV~1~ was 0.76 ±0.26 of IC and IC was 0.71 ±0.20 of FVC. FVC%, SVC%, and FEV~1~% were highly correlated in this study but not with FEV~1~/FVC, which may be because a reduction in FVC may result in a normal or mildly reduced FEV~1~/FVC due to pseudo-restriction ([@ref-34] (in press)).

In summary, TLC% cannot be replaced by FVC% and RV/TLC is most frequently and most strongly correlated with other lung function variables and consistent with FEV~1~/FVC. FEV~1~% is a marker of the severity of COPD. D~L~CO% alone represented factor 5. Although these four variables could be used to represent all 26 full lung function variables, we do not conclude that the additional variables should not be collected/examined/included in models.

Study limitations
-----------------

Diagnostic instability of COPD diagnosis has been reported in approximately 20% and 10% of individuals with mild and moderate airflow obstruction, respectively, after 4--5 years of follow-up ([@ref-2])*.* However, most (92%) of our participants had moderate to very severe airflow obstruction; therefore, we estimated that 6.7% of our participants probably had diagnostic instability. Selecting an appropriate reference value is important, e.g., TLC or FVC has been reported to be 12% lower in African Americans than in Caucasians ([@ref-22]). In this study, we arbitrarily reduced the reference values in the literature by 10--15%, as surveillance reports on reference values were unavailable and to consistently follow our previous reports ([@ref-9]). Lung size has been reported to be different between Chinese participants from southern China and northern China; however, it is difficult to trace the study participants in Taiwan, as some ancestors came from both northern and southern China. Nevertheless, the use of correlation analysis may have reduced this potential bias. In Guangzhou, China, the estimated prevalence rates of GOLD stage 2 or higher COPD in females and males are approximately 5% and 10%, respectively ([@ref-24]). Although we did not have prevalence data of COPD in Taiwan, 96% of the cohort with COPD were male and only 4% were female ([@ref-19]). The data from China are quite different from ours, which may be related to the biomass fuel smoke exposure in the Chinese female population ([@ref-24]). Although our study population was small compared to previous reports ([@ref-1]; [@ref-13]), our patients had COPD alone, whereas previous studies have enrolled COPD patients with various other lung diseases. This may raise concerns that the relationships between lung volumes and their ratios to TLC among the study participants of previous studies may be different from those in our study ([@ref-33]). In addition, our data were all obtained before bronchodilator inhalation, as pharmacological interventions may alter the relationship between volume and capacity. Hence, the findings of this study should be interpreted with caution when extrapolating to patients after bronchodilator inhalation. Furthermore, only two participants did use ultra-long-acting beta agonists in this study, so that the duration of bronchodilator withdrawal for most of the participants might be appropriate. The relationships among lung function variables in the current study may also have been different if the lung volume and capacity were expressed in a way other than % predicted. For example, a previous study reported lung volume and capacity were standardized with cubed height or adjusted with multiple linear regression analysis with adjustments for least square mean and adjustments of spirometry with *z*-scores ([@ref-38]). However, these adjustments have not yet been widely used in clinical practice, and further studies are needed to clarify this issue. In the present study, %predicted and ratio of lung volume or capacity and TLC or FVC were used instead of using absolute value in liters or mL/min/mmHg. This may have reduced confounding caused by body height, sex, and age. In addition, anemia is a factor that should be considered for adjustment when predicting D~L~CO ([@ref-23]). However, this may be a minor issue, as the hemoglobin level was 14.4 ± 1.7g/dL and 83.2% of our participants had normal hemoglobin levels (≥13 g/dL) and the adjusted coefficient for predicted D~L~CO was 0.99 ± 0.05 (5th percentile--95th percentile: 0.89--1.06). Lastly, COPD has many phenotypes, however we did not specify these phenotypes in this study.

Conclusions
===========

This study identified several collinear relationships among individual lung function variables. Selecting multiple variables with close relationships for correlation studies should be performed with caution. This study also differentiated variables for air trapping and lung hyperinflation. Lung volume measurements are necessary even when spirometry data are available. We identified four of 26 lung function variables from individual latent factors that could be used to concisely represent lung function.
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###### 94 male subjects with chronic obstructive pulmonary diseases

Three female subjects with asthma were not included. For abbreviations and unit for each variable, please refer to the data dictionary and the text body. Some missing data were encountered: cigarette smoking history in pack-year, 2, OCD score, 22, TLC and other lung volume measurements, 2, DLCO and DLCOpred, 6, and hemoglobin levels, 2.

###### 

Click here for additional data file.

The 26 lung function variables with their units. 1TLC, L2TLC% predicted, %3FRC, L4FRC% predicted, %5FRC/TLC6RV, L7RV% predicted, %8RV/TLC9Expiratory reserve volume, L10Expiratory reserve volume, ERV% predicted, %11ERV/TLC12IC, L13IC% predicted, %14IC/TLC15Inspiratory reserve volume, L16Inspiratory reserve volume, IRV% predicted, %17IRV/TLC18Diffusion capacity for cabon monoxide, D ~L~CO, mL/min/mmHg19D ~L~CO% predicted, %20Forced vital capacity, FVC, L21FVC% predicted, %22Forced expiratory volume in one second, FEV~1~, L23FEV~1~% predicted, %24FEV~1~/FVC25Slow vital capacity, SVC, L26SVC% predicted, %

TLC was defined as IC plus FRC ([@ref-39]). Thoracic gas volume was measured by panting at a rate of 1 Hz when the flow was occluded at the end of stable expiration. FRC was calculated from thoracic gas volume after adjusting for stable tidal volume. IC was measured from the end of stable expiration to the top of TLC as far as possible after panting. V~T~ was averaged from several stable breaths at rest, and IRV was measured from IC minus the averaged V~T~. ERV was measured as SVC minus IC, and RV was measured as FRC minus ERV. Predicted IC was calculated as predicted TLC minus predicted FRC, and predicted ERV was calculated as predicted FRC minus predicted RV ([@ref-12]).
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